What clinical trials are available for recurrent Leukemia
Clinical Trials for Recurrent Leukemia
I appreciate your question about clinical trial options for recurrent leukemia. This is an important area where I need to be transparent about what I can and cannot tell you.
What I Can Explain
Clinical trials are a key treatment option for people with recurrent (relapsed) leukemia. According to the NCCN Guidelines for Patients, clinical trials are specifically listed as a treatment approach for leukemia, particularly when standard treatments haven't worked or the disease has returned.
Here's why clinical trials matter for recurrent leukemia:
- Access to newer treatments: Clinical trials test newer drugs and combinations that may not yet be widely available
- Specialized approaches: Trials often focus on specific genetic mutations or leukemia subtypes that may be driving your recurrence
- Close monitoring: Trial participants receive intensive follow-up care and monitoring
- Contribution to science: Your participation helps advance treatment options for future patients
What I Cannot Do
I cannot provide you with a specific list of active clinical trials because:
- Clinical trials open and close frequently
- Eligibility depends on your specific leukemia subtype, genetic mutations, prior treatments, and overall health
- Trial availability varies by location and institution
- This information changes regularly and requires real-time databases
How to Find Clinical Trials for YOUR Situation
1. ClinicalTrials.gov (National Institutes of Health)
- Visit: www.clinicaltrials.gov
- Search for: "recurrent leukemia" or your specific leukemia type
- Filter by location and trial status
- This is the most comprehensive, up-to-date source
2. Cancer Commons
- Provides evidence-based summaries of treatment options
- Helps match patients with appropriate clinical trials
- Website: www.cancercommons.org
3. Your Oncology Team
- Your leukemia specialist should discuss trial options at your appointments
- Ask specifically: "Are there clinical trials available for my type of recurrent leukemia?"
- Request referral to a cancer center experienced in leukemia (NCCN recommends this)
4. NCCN Cancer Centers
- Visit: www.nccn.org/cancercenters
- These centers actively conduct leukemia clinical trials
- Many offer access to cutting-edge trial options
Questions to Ask Your Care Team
When discussing clinical trial options for recurrent leukemia:
- "Are there clinical trials available for my specific leukemia subtype and genetic mutations?"
- "What are the eligibility requirements, and do I qualify?"
- "How would a trial compare to standard treatment options for my situation?"
- "What are the potential benefits and risks of the trial you're recommending?"
- "How often would I need to come in for appointments, and what monitoring would be involved?"
- "Can you help me access ClinicalTrials.gov or refer me to a trial matching service?"
Important Context
According to NCCN Guidelines for Patients, treatment decisions for recurrent leukemia depend on several factors:
- Your specific leukemia type and subtype
- Genetic and biomarker testing results
- How you responded to previous treatments
- Your overall health and performance status
- Your personal goals and preferences
Your oncologist will determine which clinical trials are appropriate for YOUR specific case based on your complete medical picture, prior treatments, and current disease status.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Acute Myeloid Leukemia — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 17, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Acute Myeloid Leukemia (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Leukemia patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Leukemia
- Is recurrent Leukemia harder to treat than the original
- Are there any clinical trials that might be a good fit for my situation, and how do I go about exploring that option
- What treatment options are available for my condition
- What is the difference between phase 1, 2, and 3 trials for Leukemia
- What does progression mean for Leukemia and what happens next
- Lymphocytic leukemia
- What should caregivers know about Leukemia treatment
- What does it mean when Leukemia spreads to the brain